Pneumonia News and Research

Latest Pneumonia News and Research

All patients in study clear parasite that causes African sleeping sickness

Immtech International has announced that all 30 patients participating in the concluded Phase IIb extended dose regimen arm of its clinical trial of DB289 for treating African sleeping sickness cleared the parasite that causes African sleeping sickness within the treatment period, with no significant adverse results reported.

11 Nov 2004

Nanogen announces clinical diagnostic to simultaneously detect multiple respiratory viruses

Nanogen announced today that it is developing new analyte specific reagents (ASRs) for clinical reference laboratories to develop and validate a single test to detect six of the most common respiratory viruses.

10 Nov 2004

Researcher highlights hidden problem of smoking after pregnancy

Most women know to drop cigarettes and alcohol while they are pregnant. In fact, about half of women smokers now quit smoking when they become pregnant.

9 Nov 2004

Schwarzenegger puts tens of thousands of Californians at risk, according to Californian Nurses

The California Nurses Association condemned a decision by Gov. Arnold Schwarzenegger today, at the behest of the multi-billion dollar hospital industry, to suspend major provisions of California's law requiring safe registered nurse-to-patient staffing ratios

5 Nov 2004

Wyeth shows new Phase III data about its investigational antibiotic, tigecycline

Wyeth Pharmaceuticals recently presented exciting new Phase III data about its investigational antibiotic, tigecycline, based on a clinical trial in patients with complicated intra-abdominal infections (cIAI).

4 Nov 2004

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections

Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.

1 Nov 2004

Tamiflu significantly reduced the risk of pneumonia in patients diagnosed with flu

Treatment with the antiviral medication Tamiflu (oseltamivir phosphate) significantly reduced the risk of pneumonia in patients diagnosed with flu, according to a new retrospective cohort study of over 70,000 Americans.

1 Nov 2004

More to MRSA infection than just exposure to antibiotics

Johns Hopkins researchers report potentially life-threatening hospital infections with bacteria resistant to the antibiotic methicillin can occur even if patients havent been treated with that drug.

1 Nov 2004

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

The Food and Drug Administration (FDA) has identified about 5 million doses of influenza vaccine from foreign manufacturers; HHS has been able to recoup an additional 300,000 doses of the injectable vaccine originally bought for federal employees and the military; and a major pneumonia vaccine manufacturer plans to triple its production.

29 Oct 2004

Gastric acid-suppressive medications may increase risk of developing pneumonia

Individuals who use gastric acid-suppressive medications may be at an elevated risk of developing community-acquired pneumonia, according to an article in the October 27 issue of JAMA.

28 Oct 2004

New method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia

Research at Michigan State University found that a new test that provides a new, quicker method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia in newborns is effective more than 90 percent of the time.

22 Oct 2004

New antibody to prevent respiratory syncytial virus in premature babies

Virginia Commonwealth University researchers are studying the effectiveness of introducing a new antibody in premature infants to manage the most common form of lower respiratory tract infections in children worldwide.

21 Oct 2004

QIMR researchers have received a 5 year grant to develop a vaccine against Group A streptococcus

QIMR researchers have received a 5 year grant from the National Institutes of Health in the USA to develop a vaccine against Group A streptococcus. This extremely prestigious grant makes QIMR one of the most successful recipients of NIH funding in Australia.

18 Oct 2004

Geriatricians call for creative and wide-reaching solutions to end-of-life care for patients with dementia

Three University of Chicago geriatricians are calling for creative and wide-reaching solutions to the problem of sub-optimal end-of-life care for patients with dementia.

14 Oct 2004

New Jersey to receive additional flu vaccine

The New Jersey Department of Health and Senior Services (DHSS) received information on October 5, 2004 that, due to manufacturing problems in the United Kingdom, the United States will have only one-half of the expected supply of the influence vaccine available for this year’s flu season.

13 Oct 2004

New research points to potential new treatments for sickle cell disease

New research from the University of North Carolina at Chapel Hill reveals why red blood cells from people with sickle cell disease are stickier than healthy red cells, pointing the way to potential new treatments for sickle cell disease.

12 Oct 2004

Study finds new vaccine against pneumococcal has minor adverse effects but continued surveillance is warranted

Examination of reports from the first two years after licensure of a new vaccine against pneumococcal infections indicates that the majority of adverse effects are minor, but that continued surveillance is warranted, according to a study in the October 13 issue of JAMA.

12 Oct 2004

Pneumonia News and Research

Latest Pneumonia News and Research

All patients in study clear parasite that causes African sleeping sickness

Nanogen announces clinical diagnostic to simultaneously detect multiple respiratory viruses

Researcher highlights hidden problem of smoking after pregnancy

Schwarzenegger puts tens of thousands of Californians at risk, according to Californian Nurses

Wyeth shows new Phase III data about its investigational antibiotic, tigecycline

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections

Tamiflu significantly reduced the risk of pneumonia in patients diagnosed with flu

More to MRSA infection than just exposure to antibiotics

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

Gastric acid-suppressive medications may increase risk of developing pneumonia

New method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia

New antibody to prevent respiratory syncytial virus in premature babies

QIMR researchers have received a 5 year grant to develop a vaccine against Group A streptococcus

Geriatricians call for creative and wide-reaching solutions to end-of-life care for patients with dementia

New Jersey to receive additional flu vaccine

New research points to potential new treatments for sickle cell disease

Study finds new vaccine against pneumococcal has minor adverse effects but continued surveillance is warranted

Repeated re-testing of women with a history of chlamydia is a cost-effective strategy for preserving reproductive health

Influenza is a contagious disease caused by an RNA virus of the orthomyxoviridae family

UK's Department of Health flu immunisation campaign launches

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pneumonia News and Research

Latest Pneumonia News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in